LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 44 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,375,963 | +31.5% | 603,581 | +37.7% | 0.01% | +37.5% |
| Q1 2024 | $3,327,456 | +62.4% | 438,400 | -2.7% | 0.01% | +60.0% |
| Q4 2023 | $2,049,320 | +14.0% | 450,400 | -1.0% | 0.01% | 0.0% |
| Q3 2023 | $1,797,250 | -31.6% | 455,000 | -45.8% | 0.01% | -37.5% |
| Q2 2023 | $2,626,070 | +27.4% | 839,000 | +84.4% | 0.01% | +33.3% |
| Q1 2023 | $2,061,150 | +5.1% | 455,000 | -4.2% | 0.01% | -14.3% |
| Q4 2022 | $1,961,750 | +29.1% | 475,000 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $1,520,000 | -28.5% | 475,000 | +141.2% | 0.01% | -25.0% |
| Q4 2021 | $2,125,000 | -6.4% | 196,896 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $2,270,000 | +133.1% | 196,896 | +98.6% | 0.01% | +150.0% |
| Q2 2021 | $974,000 | +286.5% | 99,160 | +474.5% | 0.00% | +300.0% |
| Q1 2021 | $252,000 | -31.9% | 17,260 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $370,000 | +41.2% | 17,260 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $262,000 | +18.0% | 17,260 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $222,000 | – | 17,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,515,148 | $22,985,000 | 8.18% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $12,591,000 | 3.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,144,539 | $78,043,000 | 1.90% |
| Sio Capital Management, LLC | 300,591 | $4,560,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 292,184 | $4,432,000 | 0.75% |
| Vivo Capital, LLC | 799,662 | $12,131,000 | 0.70% |
| Logos Global Management LP | 330,000 | $5,006,000 | 0.64% |
| Soleus Capital Management, L.P. | 76,184 | $1,156,000 | 0.61% |
| SPHERA FUNDS MANAGEMENT LTD. | 342,064 | $5,189,000 | 0.51% |
| RA Capital Management | 1,515,151 | $22,985,000 | 0.42% |